Download Your Complimentary Copy of the Agenda

The Obesity Drug Development Summit Europe is your unique forum to learn and network with the brightest minds revolutionising the industry.

Obesity EU Brochure Cover V2 (1)

Having trouble downloading the brochure? Let us know and we’ll email it to you instead.

Shaping the Future of Obesity Drug Development: Innovation, Collaboration, and Breakthrough Science

The Obesity Drug Development Summit Europe 2025 is the premier forum for pharmaceutical leaders, biotech innovators, and academic pioneers to redefine the next generation of obesity therapies. Across three days of data-driven discussions, interactive workshops, and unparalleled networking, this summit will tackle the most pressing challenges in metabolic health—from GLP-1 combinations and muscle-preserving therapies to RNA-based innovations and precision trial design.

Join 60+ industry decision-makers in Barcelona to: 

  • Explore novel targets beyond GLP-1, including GIPR modulators, mitochondrial activators, and DNA-encoded therapies. 
  • Master payer-centric clinical trials with real-world evidence and multi-organ endpoints. 
  • Navigate manufacturing hurdles for oral formulations and extended-release injectables. 
  • Forge collaborations with key players like Novo Nordisk, Eli Lilly, and Boehringer Ingelheim. 

With a focus on sustainable efficacy, patient adherence, and commercial success, this is your opportunity to shape the future of a $100 billion market.Â